{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26"],"submitter":["Yamamoto R"],"pubmed_abstract":["<h4>Background</h4>To elucidate the association between blood glucose levels at the return of spontaneous circulation (ROSC) and neurological outcomes following out-of-hospital cardiac arrest (OHCA), a post hoc analysis was conducted using data from a prospective observational study involving 41 hospitals in Tokyo and its suburbs from 2019 to 2021. Adults with nontraumatic OHCA who achieved ROSC were included.<h4>Methods</h4>A total of 1533 patients were analyzed. A spline curve for estimating neurological outcomes (Cerebral Performance Category score ≤2 at 30 days) by blood glucose level at ROSC was generated. Patients were classified into low, moderate, and high blood glucose groups, defined as <100, 100-300, and ≥300 mg/dL, respectively. Neurological outcomes were compared using generalized estimating equations adjusted for patient and institutional characteristics.<h4>Results</h4>Favorable neurologic outcomes were fewer in the low and high blood glucose groups than in the moderate group (8/132 [6.1 %] and 62/485 [12.8 %] vs. 181/807 [22.4 %]). The adjusted model revealed that low and high glucose levels at ROSC were associated with fewer favorable outcomes (odds ratios, 0.43 [0.18-0.96] and 0.59 [0.42-0.84]). High blood glucose levels showed unfavorable effects in subgroups with cardiogenic or noncardiogenic etiology, age <65 years, and low-flow time ≤30 min, whereas low blood glucose levels showed unfavorable effects only in cardiogenic cases.<h4>Conclusions</h4>Blood glucose levels <100 and ≥300 mg/dL were associated with unfavorable neurological outcomes, with a nonlinear inverted U-shaped relationship."],"journal":["Resuscitation plus"],"pagination":["101088"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12481122"],"repository":["biostudies-literature"],"pubmed_title":["Blood glucose upon return of spontaneous circulation and neurological outcomes following out-of-hospital cardiac arrest."],"pmcid":["PMC12481122"],"pubmed_authors":["Sasaki J","Matsumura K","Suzuki M","Kaito D","Yasunaga H","Yamamoto R","Kitamura N","Homma K","SOS-KANTO 2017 Study Group","Nomura T","Aso S","Tagami T","Tamura T"],"additional_accession":[]},"is_claimable":false,"name":"Blood glucose upon return of spontaneous circulation and neurological outcomes following out-of-hospital cardiac arrest.","description":"<h4>Background</h4>To elucidate the association between blood glucose levels at the return of spontaneous circulation (ROSC) and neurological outcomes following out-of-hospital cardiac arrest (OHCA), a post hoc analysis was conducted using data from a prospective observational study involving 41 hospitals in Tokyo and its suburbs from 2019 to 2021. Adults with nontraumatic OHCA who achieved ROSC were included.<h4>Methods</h4>A total of 1533 patients were analyzed. A spline curve for estimating neurological outcomes (Cerebral Performance Category score ≤2 at 30 days) by blood glucose level at ROSC was generated. Patients were classified into low, moderate, and high blood glucose groups, defined as <100, 100-300, and ≥300 mg/dL, respectively. Neurological outcomes were compared using generalized estimating equations adjusted for patient and institutional characteristics.<h4>Results</h4>Favorable neurologic outcomes were fewer in the low and high blood glucose groups than in the moderate group (8/132 [6.1 %] and 62/485 [12.8 %] vs. 181/807 [22.4 %]). The adjusted model revealed that low and high glucose levels at ROSC were associated with fewer favorable outcomes (odds ratios, 0.43 [0.18-0.96] and 0.59 [0.42-0.84]). High blood glucose levels showed unfavorable effects in subgroups with cardiogenic or noncardiogenic etiology, age <65 years, and low-flow time ≤30 min, whereas low blood glucose levels showed unfavorable effects only in cardiogenic cases.<h4>Conclusions</h4>Blood glucose levels <100 and ≥300 mg/dL were associated with unfavorable neurological outcomes, with a nonlinear inverted U-shaped relationship.","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-06-04T00:13:06.232Z","creation":"2026-05-03T03:12:14.263Z"},"accession":"S-EPMC12481122","cross_references":{"pubmed":["41035570"],"doi":["10.1016/j.resplu.2025.101088"]}}